Role of the c-myc proto-oncogene in the proliferation of hereditary gingival fibromatosis fibroblasts

Journal of Periodontology

Volumn 75, Issue 3, 2004, Pages 360-369

  Tipton, David A ^a   Woodard III, Ernest S ^a   Baber, Mark A ^a   Dabbous, Mustafa Kh ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Fibroblasts, gingival; Fibromatosis, gingival; Genes, myc

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BROXURIDINE; COLLAGEN; DEOXYCYTIDINE TRIPHOSPHATE; DNA; FIBRONECTIN; MESSENGER RNA; MYC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; AUTOCRINE EFFECT; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE EXPRESSION; GENE FUNCTION; GINGIVA FIBROMATOSIS; HUMAN; HUMAN CELL; HYBRIDIZATION; POLYMERASE CHAIN REACTION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CELL CYCLE; CELL DIVISION; CELL LINE; CHILD; COLLAGEN; FIBROBLASTS; FIBROMATOSIS, GINGIVAL; FIBRONECTINS; GENE EXPRESSION REGULATION; GENES, MYC; GINGIVA; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER;

EID: 1842637702     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.3.360     Document Type: Article

References (48)

1. Jorgenson R, Cocker M. Variation in inheritance and expression of gingival fibromatosis. J Periodontol 1974;45: 472-477.
2. Shirasuna K, Okura M, Watatami I, Hayashido Y, Saka M, Matsuya T. Abnormal cellular property of fibroblasts from congenital gingival fibromatosis. J Oral Pathol 1989;7: 381-385.
3. Johnson B, el-Guindy M, Ammons W, Narayanan A, Page R. A defect in fibroblasts from an unidentified syndrome with gingival hyperplasia as the predominant feature. J Periodont Res 1986;21:403-413.
4. Collan Y, Ranta H, Vartio T, Perheentupa J, Raeste A. Histochemical and biochemical study of hereditary fibrous hyperplasia of the gingiva. Scand J Dent Res 1982;90:20-28.
5. Tipton DA, Howell KJ, Dabbous MKh. Increased proliferation, collagen, and fibronectin production by hereditary gingival fibromatosis fibroblasts. J Periodontol 1997;68: 524-530.
6. Varga J, Rosenbloom J, Jimenez S. Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 1987;247:597-604.
7. Sporn M, Roberts A, Wakefield L, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987;105: 1039-1045.
8. Ignotz R, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-4345.
9. Tipton DA, Dabbous MKh. Autocrine transforming growth factor β stimulation of extracellular matrix production by fibroblasts from fibrotic human gingiva. J Periodontol 1998;69:609-619.
10. 1. Mol Cell Biol 1988;8:1614-1624.
11. 1. Nature 1987;328:445-449.
12. Trojanowska M, Wu L, LeRoy E. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts. Oncogene 1988;3:477-481.
13. Evan G, Littlewood T. The role of c-myc in cell growth. Curr Opin Genet Dev 1993;3:44-49.
14. Darnell J, Lodish H, Baltimore D. Cancer. In: Molecular Cell Biology, 2nd ed. New York: W.H. Freeman and Co.; 1990:955-1002.
15. Parkes JL, Cardell RR, Hubbard FC, Meltzer A, Penn A. Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc proto-oncogene. Am J Pathol 1991;138:765-775.
16. Feghali CA, Boulware DW, Ferriss JA, Levy LS. Expression of c-myc, c-myb, and c-sis, in fibroblasts from affected and unaffected skin of patients with systemic sclerosis. Autoimmunity 1993;16:167-171.
17. Walder RY, Walder JA. Role of RNase H in hybrid-arrested translation by antisense oligonucleotide. Proc Natl Acad Sci (USA) 1988;85:5011-5015.
18. Kim SK, Wold BJ. Stable reduction of thymidine kinase activity in cells expressing high levels of antisense RNA. Cell 1985;42:129-138.
19. Scherczinger CA, Knecht DA. Systematic analysis of antisense RNA inhibition of myosin II heavy chain gene expression in Dictyostelium discoideum. Antisense Res Dev 1993;3:191-205.
20. Tipton DA, Pabst MJ, Dabbous MKh. Interleukin-1β- and tumor necrosis factor α-independent monocyte stimulation of fibroblast collagenase activity. J Cell Biochem 1990;44:253-264.
21. Robinson-Benion C, Holt JT. Antisense techniques. Methods Enzymol 1995;254:363-375.
22. Tobey R, Valdez J, Crissman H. Synchronization of human diploid fibroblasts at multiple stages of the cell cycle. Exp Cell Res 1988;179:400-416.
23. Holt JT, Redner RL, Nienhuis AW. An oligomer complimentary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol 1988;8:963-973.
24. Greenberg ME, Ziff EB. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 1984;311: 433-438.
25. Jordana M, Schulman J, McSharry C, et al. Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Resp Dis 1988;137:579-584.
26. Bordin S, Page RC, Narayanan AS. Heterogeneity of normal human diploid fibroblasts: Isolation and characterization of one phenotype. Science 1984;223:171-173.
27. Hassell TM, Stanek EJ. Evidence that healthy human gingiva contains functionally heterogeneous fibroblast subpopulations. Arch Oral Biol 1983;28:617-625.
28. Ko SD, Page RC, Narayanan AS. Fibroblast heterogeneity and prostaglandin regulation of subpopulations. Proc Natl Acad Sci (USA) 1977;74:3429-3432.
29. Coletta RD, Almeida OP, Graner E, Page RC, Bozzo L. Differential proliferation of fibroblasts cultured from hereditary gingival fibromatosis and normal gingiva. J Periodont Res 1998;33:469-475.
30. Thompson K, Holliday R. Genetic effects on the longevity of cultured human fibroblasts. Enhanced growth potential of cystic fibrosis cells. Gerontology 1983;29: 97-101.
31. de Andrade CR, Cotrin P, Graner E, Almeida OP, Sauk JJ, Coletta RD. Transforming growth factor-β1 autocrine stimulation regulates fibroblast proliferation in hereditary gingival fibromatosis. J Periodontol 2001;72:1726-1733.
32. Clark D. Gingival fibromatosis and its related syndromes. A review. J Can Dent Assoc 1987;2:137-140.
33. Witkop CR. Heterogeneity in gingival fibromatosis. Birth Defects Orig Artic Ser 1971;7:210-221.
34. Hart TC, Pallos D, Bozzo L, et al. Evidence of genetic heterogeneity for hereditary gingival fibromatosis. J Dent Res 2000;79:1758-1764.
35. Shapiro SD, Jorgenson RJ. Heterogeneity in genetic disorders that affect the orofacies. Birth Defects Original Artic Ser 1983;19:155-165.
36. Hart TC, Pallos D, Bowden DW, et al. Genetic linkage of hereditary gingival fibromatosis to chromosome 2p21. Am J Hum Genet 1998;62:876-883.
37. Xiao S, Wang X, Qu B, et al. Refinement of the locus for automosal domninant hereditary gingival fibromatosis (GINGF) to a 3.8-cM region on 2p21. Genomics 2000;68: 247-252.
38. Xiao S, Bu L, Zhu L, et al. A new locus for hereditary gingival fibromatosis (GINGF2) maps to 5q13-q22. Genomics 2001;74:180-185.
39. Fryns JP. Gingival fibromatosis and partial duplication of the short arm of chromosome 2 (dup(2)(p13-p21). Ann Genet 1996:39:54-55.
40. Shashi V, Pallos D, Pettenati MJ, et al. Genetic heterogeneity of gingival fibromatosis on chromosome 2p. J Med Genet 1999;36:683-686.
41. Macias-Flores MA, Garcia-Cruz D, Rivera H, et al. A new form of hypertrichosis inherited as an X-linked dominant trait. Hum Genet 1984;66:66-70.
42. Hart TC, Zhang Y, Gorry MC, et al. A mutation in the SOS1 gene causes hereditary gingival fibromatosis. Am J Hum Genet 2002;70:943-954.
43. Noonan K, Beck TA, Holzmayer J, et al. Quantitative analysis of MDR1 (multidrug resistance) expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci (USA) 1990;87:7160-7164.
44. Kelly K, Cochran B, Stiles C, Leder P. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 1983;35:603-610.
45. Heufelder A, Bahn RS. Modulation of cellular functions in retro-orbital fibroblasts using antisense oligonucleotides targeting the c-myc protooncogene. Invest Ophthalmol Vis Sci 1995;36:1420-1432.
46. Capeans C, Piñeiro A, Dominguez F, et al. A c-myc antisense oligonucleotide inhibits human retinal pigment cell proliferation. Exp Eye Res 1996;66:581-589.
47. Bondurant MC, Yamashita T, Muta K, Krantz SB, Koury MJ. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells. J Cell Physiol 1996;168:255-263.
48. Cerutti J, Trapasso F, Battaglia C, et al. Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines. Clin Cancer Res 1996;2:119-126.